Concall Intelligence
Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.
Management evidence
Generated 22 Oct, 2:10 am IST · click a summary to inspect source-linked evidence for this results quarter.
| Company | Call and sources | Reported result | Management outlook | Evidence-led conclusion | Review |
|---|---|---|---|---|---|
| SHOPERSTOP Shoppers Stop Limited Consumer · Small | Sep 2026 21 Oct 2026 Transcript verified | Bad 22/100 | Optimistic outlook No comparable prior call Guidance raised | Shoppers Stop delivered modest top‑line growth and a turnaround to profitability, driven by strong festive demand, premiumisation initiatives and new store openings, while highlighting ongoing work on inventory and working‑capital optimisation. Evidence summary ready | |
| HERITGFOOD Heritage Foods Limited FMCG · Micro | Sept 2026 19 Oct 2026 Transcript verified | Bad 0/100 | Cautious outlook Broadly unchanged No measurable guidance | Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially. Evidence summary ready | |
| GAJA Gaja Alternative Asset Management Limited Financial Services · Micro | Sep 2026 19 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending | |
| ASTERDM Aster DM Healthcare Limited Pharma · Small | Sep 2026 19 Oct 2026 Transcript verified | Result pending No matching current-quarter result row | Optimistic outlook Broadly unchanged No measurable guidance | The successful merger and strong proforma FY2026 results, coupled with clear strategic priorities for integration and network expansion, suggest the company is on track to leverage scale and clinical depth. Management's focus on capital efficiency and margin improvement supports the long-term value creation thesis. Evidence summary ready | |
| HCLTECH HCL Technologies Limited IT · Large | Sept 2026 15 Oct 2026 Transcript verified | Good 70/100 | Cautious outlook Broadly unchanged Guidance maintained | HCLTech delivered solid top‑line growth and margin expansion, driven by strong Advanced AI services and record bookings, while software revenue declined and margin guidance remains cautious. Evidence summary ready | |
| COCHINSHIP Cochin Shipyard Limited Industrials · Mid | Sep 2026 10 Oct 2026 Preliminary brief | Result pending No matching current-quarter result row | Optimistic outlook No comparable prior call No measurable guidance | The company demonstrates strong order book visibility, supported by significant capacity expansion projects recently commissioned and others in the pipeline. Strategic JVs and acquisitions are aimed at diversifying capabilities and market reach, suggesting continued growth momentum. Evidence summary ready | |
| WABAG VA Tech Wabag Limited Infra · Micro | Sept 2026 7 Oct 2026 Transcript filed | Result pending No matching current-quarter result row | Outlook pending No comparable prior call Guidance pending | The available source has not produced sufficient structured evidence. Summary pending |